Citations for
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.
Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR.
Hum Mol Genet 18(4):767-78. Epub 2008 Nov 14. 2009
Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer.
Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, Paty PB, Gerald WL, Notterman DA, Domany E.
Proc Natl Acad Sci U S A 106(17):7131-6. Epub 2009 Apr 9.PMID: 19359472 2009
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.
Kraus DM, Elliott GS, Chute H, Horan T, Pfenninger KH, Sanford SD, Foster S, Scully S, Welcher AA, Holers VM.
J Immunol 176(7):4419-30. 2006
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C, Jackson A, Maguire K, Wood J, Gollin S, Ishwad C, Paterson I, Prime S, Parkinson K, Bell S, Woods G, Markham A, Oliver R, Woodward R, Sloan P, Dixon M, Read A, Thakker N.
Genes Chromosomes Cancer 37(2):132-40. 2003
Identification of two new members of the CSMD gene family small star, filled.
Lau WL, Scholnick SB.
Genomics 82(3):412-5. 2003
The role of CSMD1 in head and neck carcinogenesis.
Scholnick SB, Richter TM.
Genes Chromosomes Cancer 38(3):281-3. No abstract available. 2003
Transcript map of the 8p23 putative tumor suppressor region.
Sun PC, Uppaluri R, Schmidt AP, Pashia ME, Quant EC, Sunwoo JB, Gollin SM, Scholnick SB.
Genomics 75(1-3):17-25. 2001